Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121820772 | 12182077 | 2 | F | 20160215 | 20160726 | 20160315 | 20160801 | EXP | FR-AMGEN-FRASP2016029440 | AMGEN | 67.00 | YR | E | F | Y | 0.00000 | 20160801 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121820772 | 12182077 | 1 | PS | ARANESP | DARBEPOETIN ALFA | 1 | Subcutaneous | 60 MUG, Q2WK | Y | 103951 | 60 | UG | SOLUTION FOR INJECTION | QOW | |||||
| 121820772 | 12182077 | 2 | SS | VELCADE | BORTEZOMIB | 1 | Subcutaneous | 1.3 MG/M2 (2.2MG DOSE FOR A TOTAL OF 8 CYCLES), UNK | 0 | 1.3 | MG/M**2 | ||||||||
| 121820772 | 12182077 | 3 | SS | ALKERAN | MELPHALAN | 1 | Oral | (116M DAYS) UNK, UNK | 0 | ||||||||||
| 121820772 | 12182077 | 4 | SS | PREDNISONE. | PREDNISONE | 1 | Oral | 102 MG, UNK | 0 | 102 | MG | ||||||||
| 121820772 | 12182077 | 5 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | 40 MG/M2, UNK | 0 | 40 | MG/M**2 | ||||||||
| 121820772 | 12182077 | 6 | C | ESOMEPRAZOLE | ESOMEPRAZOLE | 1 | 500 MG, UNK | 0 | 500 | MG | |||||||||
| 121820772 | 12182077 | 7 | C | ZELITREX | VALACYCLOVIR HYDROCHLORIDE | 1 | 500 MG, UNK | 0 | 500 | MG | |||||||||
| 121820772 | 12182077 | 8 | C | AMIODARONE | AMIODARONE | 1 | 0 | ||||||||||||
| 121820772 | 12182077 | 9 | C | PRAVASTATIN. | PRAVASTATIN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 121820772 | 12182077 | 1 | Anaemia |
| 121820772 | 12182077 | 2 | Plasma cell myeloma |
| 121820772 | 12182077 | 3 | Plasma cell myeloma |
| 121820772 | 12182077 | 4 | Plasma cell myeloma |
| 121820772 | 12182077 | 5 | Plasma cell myeloma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 121820772 | 12182077 | OT |
| 121820772 | 12182077 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 121820772 | 12182077 | Atrial fibrillation | |
| 121820772 | 12182077 | Cardiac failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 121820772 | 12182077 | 1 | 201507 | 0 | ||
| 121820772 | 12182077 | 2 | 20150313 | 20151231 | 0 | |
| 121820772 | 12182077 | 3 | 201407 | 0 | ||
| 121820772 | 12182077 | 5 | 201507 | 0 | ||
| 121820772 | 12182077 | 6 | 201503 | 0 | ||
| 121820772 | 12182077 | 7 | 201503 | 0 |